# Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

> **NCT05082519** · PHASE2 · RECRUITING · sponsor: **Etan Orgel** · enrollment: 240 (estimated)

## Conditions studied

- B-cell Acute Lymphoblastic Leukemia
- Obesity

## Interventions

- **BEHAVIORAL:** IDEAL2 Intervention

## Key facts

- **NCT ID:** NCT05082519
- **Lead sponsor:** Etan Orgel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-12
- **Primary completion:** 2026-10-15
- **Final completion:** 2031-10-15
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082519, "Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05082519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*